About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effects of Sugary Drink Warning Labels | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT03654586

Effects of Sugary Drink Warning Labels

The primary objective of this study is to determine to what degree sugary drink warning labels increase consumers' knowledge about the potential health harms of sugary drinks and reduce sugary drink i...

Lead sponsor: University of Pennsylvania•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Pennsylvania

Collaborators

Drexel University
New York University
University of Connecticut

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•be a primary caregiver of a child under 12 years old;
•be ≥18 years old;
•read and speak English;
•drink sugary drinks at least twelve times per month (\~three times per week) and have a child who does the same
•be the primary grocery shopper for their family;
•have regular internet access.

Exclusion Criteria

•not a primary caregiver of a child under 12 years old
•\<18 years old
•cannot read and speak English
•does not drink sugary drinks at least 12 times per month and have a child who does the same
•is not the primary grocery shopper for their family
•does not have regular internet access

Related studies

Effect of the Digital Livsstilsverktyget in Conjunction With a Large Language Model on the Prevention of Type 2 Diabetes

NCT07659535 · Type 2 Diabetes

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)

NCT07102043 · Cystic Fibrosis Related Diabetes

RECRUITINGPhase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

NCT07595549 · Obesity, Overweight and/or Obesity, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 23, 2021Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment337

Start dateJul 2018

Last updatedApr 23, 2021

Condition

Obesity Diabetes Weight Gain

Locations shown

Blockley Hall

Philadelphia, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 23, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions